Symic Biomedical (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- January 06, 2015
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $15,000,000
Company Info
- Founders
- Ken Horne
- Company Description
- Symic Biomedical is developing a new category of therapeutics that offer an exciting and biologically innovative approach to treating disease. Symic's compounds function like proteoglycans, important structural and functional macromolecules native to the ECM (extracellular matrix). The ECM is the non-cellular component of tissues that is critical for healthy tissue function.
- Market
- Therapeutics
- Location
- San Francisco, CA, USA
- Coinvestors
- Ally Bridge Group, Den Danske Forskningsfond, InCube Ventures, Mission Bay Capital, Mitsui Global Investment, Purdue Foundry Investment Fund, QB3